Viewpoints: Dual-blocking antibody against VEGF-A and angiopoietin-2 for treating vascular diseases of the eye: forum
Faricimab, a bispecific antibody that targets the endothelial cell growth factors vascular endothelial growth factor-A (VEGF-A) and angiopoietin-2 (Angpt2), was recently approved for treating neovascular age-related macular degeneration and diabetic macular edema. Here, Koh and Augustin review how m...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
May 2022
|
| In: |
Trends in molecular medicine
Year: 2022, Jahrgang: 28, Heft: 5, Pages: 347-349 |
| ISSN: | 1471-499X |
| DOI: | 10.1016/j.molmed.2022.03.004 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.molmed.2022.03.004 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1471491422000727 
|
| Verfasserangaben: | Gou Young Koh, Hellmut G. Augustin, and Peter A. Campochiaro |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1881572749 | ||
| 003 | DE-627 | ||
| 005 | 20240307075346.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.molmed.2022.03.004 |2 doi | |
| 035 | |a (DE-627)1881572749 | ||
| 035 | |a (DE-599)KXP1881572749 | ||
| 035 | |a (OCoLC)1425215238 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Koh, Gou Young |d 1957- |e VerfasserIn |0 (DE-588)1161890211 |0 (DE-627)1025424069 |0 (DE-576)507012305 |4 aut | |
| 245 | 1 | 0 | |a Viewpoints: Dual-blocking antibody against VEGF-A and angiopoietin-2 for treating vascular diseases of the eye |b forum |c Gou Young Koh, Hellmut G. Augustin, and Peter A. Campochiaro |
| 264 | 1 | |c May 2022 | |
| 300 | |b Illustrationen | ||
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar: 5 April 2022, Artikelversion: 28 April 2022 | ||
| 500 | |a Gesehen am 26.02.2024 | ||
| 520 | |a Faricimab, a bispecific antibody that targets the endothelial cell growth factors vascular endothelial growth factor-A (VEGF-A) and angiopoietin-2 (Angpt2), was recently approved for treating neovascular age-related macular degeneration and diabetic macular edema. Here, Koh and Augustin review how mechanistic studies have translated into therapies, while Campochiaro evaluates their impact and value for clinical practice. | ||
| 700 | 1 | |a Augustin, Hellmut |d 1959- |e VerfasserIn |0 (DE-588)102307737X |0 (DE-627)717361470 |0 (DE-576)171124766 |4 aut | |
| 700 | 1 | |a Campochiaro, Peter |e VerfasserIn |0 (DE-588)1321695896 |0 (DE-627)1881573737 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Trends in molecular medicine |d Amsterdam [u.a.] : Elsevier Science, 2001 |g 28(2022), 5 vom: Mai, Seite 347-349 |h Online-Ressource |w (DE-627)391368036 |w (DE-600)2155736-6 |w (DE-576)252209338 |x 1471-499X |7 nnas |a Viewpoints: Dual-blocking antibody against VEGF-A and angiopoietin-2 for treating vascular diseases of the eye forum |
| 773 | 1 | 8 | |g volume:28 |g year:2022 |g number:5 |g month:05 |g pages:347-349 |g extent:3 |a Viewpoints: Dual-blocking antibody against VEGF-A and angiopoietin-2 for treating vascular diseases of the eye forum |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.molmed.2022.03.004 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1471491422000727 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240226 | ||
| 993 | |a Editorial | ||
| 994 | |a 2022 | ||
| 998 | |g 102307737X |a Augustin, Hellmut |m 102307737X:Augustin, Hellmut |d 60000 |d 65000 |e 60000PA102307737X |e 65000PA102307737X |k 0/60000/ |k 1/60000/65000/ |p 2 | ||
| 999 | |a KXP-PPN1881572749 |e 4491090335 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Online verfügbar: 5 April 2022, Artikelversion: 28 April 2022","Gesehen am 26.02.2024"],"recId":"1881572749","language":["eng"],"person":[{"family":"Koh","given":"Gou Young","display":"Koh, Gou Young","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Augustin, Hellmut","given":"Hellmut","family":"Augustin"},{"family":"Campochiaro","given":"Peter","display":"Campochiaro, Peter","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title_sort":"Viewpoints: Dual-blocking antibody against VEGF-A and angiopoietin-2 for treating vascular diseases of the eye","title":"Viewpoints: Dual-blocking antibody against VEGF-A and angiopoietin-2 for treating vascular diseases of the eye","subtitle":"forum"}],"physDesc":[{"extent":"3 S.","noteIll":"Illustrationen"}],"relHost":[{"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"2001-","publisher":"Elsevier Science","dateIssuedKey":"2001"}],"id":{"issn":["1471-499X"],"zdb":["2155736-6"],"eki":["391368036"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Trends in molecular medicine","title":"Trends in molecular medicine"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 21.11.23"],"disp":"Viewpoints: Dual-blocking antibody against VEGF-A and angiopoietin-2 for treating vascular diseases of the eye forumTrends in molecular medicine","language":["eng"],"recId":"391368036","pubHistory":["7.2001 -"],"part":{"extent":"3","text":"28(2022), 5 vom: Mai, Seite 347-349","volume":"28","pages":"347-349","issue":"5","year":"2022"}}],"name":{"displayForm":["Gou Young Koh, Hellmut G. Augustin, and Peter A. Campochiaro"]},"origin":[{"dateIssuedDisp":"May 2022","dateIssuedKey":"2022"}],"id":{"eki":["1881572749"],"doi":["10.1016/j.molmed.2022.03.004"]}} | ||
| SRT | |a KOHGOUYOUNVIEWPOINTS2022 | ||